Angiotech to redeem $16 million of senior secured floaters due 2013

By Tali David

Minneapolis, March 18 - Angiotech Pharmaceuticals, Inc. plans to redeem $16 million of its senior secured floating-rate notes due 2013, according to a press release.

The notes will be redeemed at par plus accrued interest on April 17.

As of March 18, $60 million of the notes are outstanding.

Deutsche Bank National Trust Co. is the trustee.

Angiotech makes medical devices and is based in Vancouver, B.C.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.